🇺🇸 L- DOPA in United States

350 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyskinesia — 57 reports (16.29%)
  2. Fall — 56 reports (16%)
  3. Drug Ineffective — 34 reports (9.71%)
  4. General Physical Health Deterioration — 34 reports (9.71%)
  5. Hallucination — 33 reports (9.43%)
  6. On And Off Phenomenon — 28 reports (8%)
  7. Parkinson^S Disease — 28 reports (8%)
  8. Depression — 27 reports (7.71%)
  9. Dysphagia — 27 reports (7.71%)
  10. Nausea — 26 reports (7.43%)

Source database →

L- DOPA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is L- DOPA approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for L- DOPA in United States?

Shaare Zedek Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.